USA – Circle Cardiovascular Imaging Inc., a Calgary, AB, Canada-based provider of cardiovascular imaging solutions, received a strategic growth investment from Thoma Bravo.
The amount of the deal – which is expected to close in the second quarter of 2022 – was not disclosed. The investment is expected to drive future investment in product innovation, extend Circle CVI’s market leadership position and fuel future growth. Led by Greg Ogrodnick, CEO and Co-Founder, Matthias Friedrich, Chief Design Officer and Co-Founder, Circle CVI is a provider of AI-based cardiac imaging and reporting solutions, including cardiac MRI (“CMR”) and cardiac computerized tomography (“CT”) imaging post-processing software. The company has developed a deep portfolio of specialized, accurate and intuitive solutions that enable physicians to deliver the highest quality care to their patients. Circle CVI’s solutions are an integral part of precision medicine and are now used by thousands of clinical users, at both hospitals and academic institutions, in more than 50 countries. 21/03/2022
